Company: DERM
Filing Date: 2025-04-18
Form Type: PRE 14A
Source: 0001104659-25-036338
Chunk: 33

Company: Journey Medical Corp
Filing Date: 2025-04-18
Form: PRE 14A
Chunk 33
---
2026, and May 1, 2027. Timing of Equity Awards While we have no set policy or practice regarding the timing of stock option awards or similar instruments in relation to the disclosure of material nonpublic information, we do not timethe release of material information to affect the value of stock options.In general, the timing of stock option awards is dictated by the event or circumstance giving rise to the award and the schedules of the directors responsible for approving the award. In 2024, options were not issued to our named executive officers during the period beginning four business days before and ending one business day after the filing of a Form 10-Q, Form 10-K or Form 8-K that discloses material nonpublic information.If, in the future, a stock option grant is made at a time that material nonpublic information exists, the directors approving the award would be responsible for considering the anticipated effect of that information on our stock price and would take such effect into account when sizing and pricing the award. Clawback Policy Pursuant to Nasdaq listing requirements, we have adopted a policy providing for the recovery of erroneously awarded incentive-based compensation received by our executive officers or the executive officers of one of our subsidiaries during an applicable recovery period (the “Clawback Policy”). Under the Clawback Policy, in the event that financial results upon which a cash or equity-based incentive award was based becomes the subject of a financial restatement that is required because of material non-compliance with financial reporting requirements, the Compensation Committee will conduct a review of awards covered by the Clawback Policy and recoup any erroneously awarded incentive-based compensation to ensure that the ultimate award reflects the financial results as restated. The Clawback Policy covers any cash or equity-based incentive compensation award that was paid, earned or granted to covered executive officers during the last completed three fiscal years immediately preceding the date on which we are required to prepare the accounting restatement.

19

TABLE OF CONTENTS

Equity Compensation Plan Information The following table summarizes information about our equity compensation plans by type as of December 31, 2024.**

| Plan Category                                               
 ​                                                           | ​ 
 ​ | ​ 
 ​ | Number ofSecurities to BeIssued uponExercise ofOutstandingOptions,Warrants andRights (#)(1) 
 (a)                                                                                         |   |           |   | ​ 
 ​ | ​ 
 ​ | WeightedAverageExercise Price ofOutstandingOptions,Warrants andRights ($)(2) 
 (b)                                                                          |   |      |   | ​